EUVIMEDEUVIMED entdecken
Open Access

Clinical benefit of range uncertainty reduction in proton treatment planning based on dual-energy CT for neuro-oncological patients

Vicki Trier Taasti iD, Esther Decabooter, Daniëlle Eekers, Inge Compter, Ilaria Rinaldi, Marta Bogowicz, Tim van der Maas, Esther Kneepkens, Jacqueline Schiffelers, Cissy Stultiens, Nicole Hendrix, Mirthe Pijls und 4 weitere

The British Journal of Radiology · 2023

DOI: 10.1259/bjr.20230110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The British Journal of Radiology, 2023. Verfasst von Vicki Trier Taasti und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology (MAASTRO), GROW - School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Nethe…. Hauptthemen laut MEDLINE: Protons, Proton Therapy. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Several studies have shown that dual-energy CT (DECT) can lead to improved accuracy for proton range estimation. This study investigated the clinical benefit of reduced range uncertainty, enabled by DECT, in robust optimisation for neuro-oncological patients.

Methods

DECT scans for 27 neuro-oncological patients were included. Commercial software was applied to create stopping-power ratio (SPR) maps based on the DECT scan. Two plans were robustly optimised on the SPR map, keeping the beam and plan settings identical to the clinical plan. One plan was robustly optimised and evaluated with a range uncertainty of 3% (as used clinically; denoted 3%-plan); the second plan applied a range uncertainty of 2% (2%-plan). Both plans were clinical acceptable and optimal. The dose–volume histogram parameters were compared between the two plans. Two experienced neuro-radiation oncologists determined the relevant dose difference for each organ-at-risk (OAR). Moreover, the OAR toxicity levels were assessed.

Results

For 24 patients, a dose reduction >0.5/1 Gy (relevant dose difference depending on the OAR) was seen in one or more OARs for the 2%-plan; e.g. for brainstem D0.03cc in 10 patients, and hippocampus D40% in 6 patients. Furthermore, 12 patients had a reduction in toxicity level for one or two OARs, showing a clear benefit for the patient.

Conclusion

Robust optimisation with reduced range uncertainty allows for reduction of OAR toxicity, providing a rationale for clinical implementation. Based on these results, we have clinically introduced DECT-based proton treatment planning for neuro-oncological patients, accompanied with a reduced range uncertainty of 2%. Advances in knowledge: This study shows the clinical benefit of range uncertainty reduction from 3% to 2% in robustly optimised proton plans. A dose reduction to one or more OARs was seen for 89% of the patients, and 44% of the patients had an expected toxicity level decrease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProtonsProton TherapyHumansUncertaintyTomography, X-Ray ComputedRadiotherapy Planning, Computer-Assisted

Substanzen

Protons

Autor:innen und Institutionen

  • Department of Radiation Oncology (MAASTRO), GROW - School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands.

ORCID-Profile: Vicki Trier Taasti

Zitieren

APA

Taasti, V. T., Decabooter, E., Eekers, D., Compter, I., Rinaldi, I., Bogowicz, M., van der Maas, T., Kneepkens, E., Schiffelers, J., Stultiens, C., Hendrix, N., Pijls, M., Emmah, R., Fonseca, G. P., Unipan, M., & van Elmpt, W. (2023). Clinical benefit of range uncertainty reduction in proton treatment planning based on dual-energy CT for neuro-oncological patients. The British Journal of Radiology. https://doi.org/10.1259/bjr.20230110

Vancouver

Taasti VT, Decabooter E, Eekers D, Compter I, Rinaldi I, Bogowicz M, et al. Clinical benefit of range uncertainty reduction in proton treatment planning based on dual-energy CT for neuro-oncological patients. The British Journal of Radiology. 2023. doi:10.1259/bjr.20230110

BibTeX
@article{Taasti2023,
  author = {Taasti, Vicki Trier and Decabooter, Esther and Eekers, Daniëlle and Compter, Inge and Rinaldi, Ilaria and Bogowicz, Marta and van der Maas, Tim and Kneepkens, Esther and Schiffelers, Jacqueline and Stultiens, Cissy and Hendrix, Nicole and Pijls, Mirthe and Emmah, Rik and Fonseca, Gabriel Paiva and Unipan, Mirko and van Elmpt, Wouter},
  title = {Clinical benefit of range uncertainty reduction in proton treatment planning based on dual-energy CT for neuro-oncological patients},
  journal = {The British Journal of Radiology},
  year = {2023},
  doi = {10.1259/bjr.20230110}
}
Kostenlos starten →